Center-Authored Papers

Filters: Author is Appelbaum, Fredrick R  [Clear All Filters]
A
Achille NJ, Othus M, Phelan K, Zhang S, Cooper K, Godwin JE, Appelbaum FR, Radich JP, Erba HP, Nand S et al..  2016.  Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients.. Leukemia research. Abstract
Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M et al..  2014.  SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia.. British journal of haematology. Abstract
Advani AS, McDonough S, Copelan E, Willman C, Mulford DA, List AF, Sekeres MA, Othus M, Appelbaum FR.  2014.  SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia.. British journal of haematology. Abstract
Advani AS, Gundacker HM, Sala-Torra O, Radich JP, Lai R, Slovak ML, Lancet JE, Coutre SE, Stuart RK, Mims MP et al..  2010.  Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.. British journal of haematology. 151(5):430-4. Abstract
Alousi AM, Le-Rademacher J, Saliba RM, Appelbaum FR, Artz A, Benjamin J, Devine SM, Kan F, Laughlin MJ, Lazarus HM et al..  2013.  Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood. Abstract
Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders JE.  1993.  Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(12):2342-50. Abstract
Appelbaum FR.  2012.  Improved outcomes with allogeneic hematopoietic cell transplantation.. Best practice & research. Clinical haematology. 25(4):465-71. Abstract
Appelbaum FR.  2009.  Optimising the conditioning regimen for acute myeloid leukaemia.. Best practice & research. Clinical haematology. 22(4):543-50. Abstract
Appelbaum FR.  2011.  The role of hematopoietic cell transplantation as therapy for myelodysplasia.. Best practice & research. Clinical haematology. 24(4):541-7. Abstract
Appelbaum FR.  2014.  Indications for allogeneic hematopoietic cell transplantation for acute myeloid leukemia in the genomic era.. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. 34:e327-33. Abstract
Appelbaum FR.  2012.  Retrospective. E. Donnall Thomas (1920-2012).. Science (New York, N.Y.). 338(6111):1163.
Appelbaum FR.  2008.  Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available.. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. :412-7. Abstract
Appelbaum FR.  2008.  Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).. Best practice & research. Clinical haematology. 21(1):85-92. Abstract
Appelbaum FR, Matthews DC, Eary JF, Badger CC, Kellogg M, Press OW, Martin PJ, Fisher DR, Nelp WB, Thomas ED.  1992.  The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.. Transplantation. 54(5):829-33. Abstract
Appelbaum FR, Badger CC, Bernstein ID, Buckner CD, Deeg HJ, Eary JF, Matthews DC, Press OW, Storb R, Thomas ED.  1992.  Is there a better way to deliver total body irradiation? Bone marrow transplantation. 10 Suppl 1:77-81. Abstract
Appelbaum FR.  2016.  Consolidation chemotherapy prior to hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.. Best practice & research. Clinical haematology. 29(4):365-371. Abstract
Appelbaum FR.  2012.  Haematological cancer: The rule of three in AML induction-is cladribine the answer? Nature reviews. Clinical oncology. 9(7):376-7.
Appelbaum FR.  2012.  Pursuing the goal of a donor for everyone in need.. The New England journal of medicine. 367(16):1555-6.
Appelbaum FR.  2008.  Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(18):2927-9.
Appelbaum FR, Radich JP.  2017.  CHIPs and engraftment dips.. Blood. 130(1):7-9.
Appelbaum FR.  2014.  Alternative donor transplantation for adults with acute leukemia.. Best practice & research. Clinical haematology. 27(3-4):272-7. Abstract
Appelbaum FR.  2011.  Preparative Regimens and Ageism.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(10):1419-20.
Appelbaum FR.  2008.  What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)? Best practice & research. Clinical haematology. 21(4):667-75. Abstract
Appelbaum FR, Meshinchi S.  2017.  Measure for Measure: Measuring the Impact of Measuring Residual Disease in Acute Myeloid Leukemia.. Journal of oncology practice. 13(8):481-483.
Appelbaum FR.  2011.  Unrelated hematopoietic stem cell donors as research subjects.. Bone marrow transplantation. 46(1):14.